Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.
N Engl J Med. 2019 Aug 1;381(5):432-443. doi: 10.1056/NEJMoa1817073.
N Engl J Med. 2019.
PMID: 31365801
Free PMC article.
Clinical Trial.